Is there evidence from biomarkers of systemic involvement in COPD exacerbations? No

Medicine and Dentistry

• Acute Phase Protein 12%
• Adipose Tissue 12%
• Airflow 12%
• Airway Obstruction 12%
• Anti-Inflammatory Drug 25%
• Apoplexy 12%
• Association 12%
• Attention 12%
• Biological Marker 12%
• Bone Marrow 12%
• Bronchodilating Agent 12%
• Bronchospasm 12%
• Cardiac Dysrhythmia 12%
• Chemokine 12%
• Chronic Disease 25%
• Chronic Obstructive Pulmonary Disease 100%
• Circulation 25%
• Cohort Effect 12%
• Corticosteroid 12%
• Cytokine 37%
• Depression 12%
• Development 12%
• Disease Exacerbation 25%
• Diseases 25%
• Dyspnea 12%
• Exercise 12%
• Functional Disease 12%
• Heart Failure 12%
• Hyperinflation 25%
• Hyperlipidemia 12%
• Inflammatory Cell 12%
• Ischemic Heart Disease 12%
• Liver 12%
• Malignant Neoplasm 12%
• Mediator 12%
• Morbidity 12%
• Mortality 12%
• Muscle Function 12%
• Muscle Weakness 12%
• Obesity 12%
• Organ 25%
• Patient 50%
• Pneumonia 12%
• Quality of Life 12%
• Respiratory Muscle 25%
• Respiratory System 12%
• Serositis 75%
• Skeletal Muscle 12%
• Smoking 12%
• Surgery 25%
• Symptom 12%
• Systemic Disease 12%
• Therapeutic Procedure 12%
• Upregulation 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Phase Protein 12%
• Airway Obstruction 12%
• Biological Marker 12%
• Bronchodilating Agent 12%
• Bronchospasm 12%
• Chemokine 12%
• Chronic Disease 25%
• Chronic Obstructive Lung Disease 100%
• Clinical Study 25%
• Comorbidity 25%
• Corticosteroid 12%
• Cytokine 37%
• Depression 12%
• Disease Exacerbation 25%
• Diseases 25%
• Dyspnea 12%
• Epidemiology 12%
• Functional Disease 12%
• Heart Arrhythmia 12%
• Heart Failure 12%
• Hyperlipidemia 12%
• Inflammation 12%
• Ischemic Heart Disease 12%
• Malignant Neoplasm 12%
• Morbidity 12%
• Mortality 12%
• Muscle Weakness 12%
• Obesity 12%
• Osteoporosis 12%
• Pneumonia 12%
• Symptom 12%
• Systemic Disease 12%